Table 2.

Characteristics of MGRS-related renal disorders with nonorganized Ig deposits and without Ig deposits

DiseaseRenal pathologyRenal manifestationsExtrarenal manifestationsHematologic findingsHematologic diagnosis
MGRS-related renal disorders with nonorganized Ig deposits      
Monoclonal immunoglobulin deposition disease LM: nodular glomerulosclerosis (2/3 of cases) with thickened TBM
IF: linear deposits along GBM, TBM, and vessels
LCDD: LC-only deposits (mostly κ)
HCDD: HC-only deposits with CH1 deletion (mostly γ)
LHCDD: deposits containing 1 LC and 1 HC lacking CH1 (mostly γ)
EM: punctate linear amorphous deposits along GBM, TBM, vessels 
CKD (median s.creat. 3  mg/dL)
Proteinuria (median 2  g/d)
Nephrotic syndrome (22%),
Hematuria (60%)
Hypertension (60%-80%) 
Common in LCDD (35%):
Cardiac disease
Liver disease
Peripheral neuropathy 
Positive serum/urine EP/IFix: 90%
Abnormal sFLC level: 99%-100%
Plasma cell clone: 95%-100%
Lymphocytic/LPC clone: <5%
Hypocomplementemia (low C4) if HCDDγ1 or HCDDγ3 
MGRS: 65%-80%
MM: 20%-35%
WM/B-cell lymphoma: 2% 
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits LM: MPGN, EPGN, MGN
IF: monotypic IgG (mostly IgG3κ, rarely IgM, IgA, LC only); granular deposits in mesangium and CW
EM: discontinuous nonorganized glomerular deposits 
CKD (mean s.creat. 2.8  mg/dL)
Heavy proteinuria (mean 6  g/d)
Nephrotic syndrome (50%)
Hematuria (80%)
Hypertension (38%) 
Absent Positive serum/urine EP/IFix: 20%-30%
Abnormal sFLC: 20%
Plasma cell clone: ~10%
Lymphocytic/LPC clone: ~10%
Hypocomplementemia 20%
Negative tests for cryoglobulins 
MGRS: 95%
MM: 3%-4%
WM/B-cell lymphoma: 1% 
MGRS-related renal disorders without Ig deposits      
C3GP with monoclonal gammopathy LM: MPGN, MesPGN, EPGN
IF: granular deposits of C3 only in mesangium and CW
EM:
C3GN: less electron dense subendothelial/subepithelial/ mesangial deposits
Dense deposit disease: highly electron dense sausage-like deposits within GBM 
CKD (median s.creat.1.8  mg/dL)
Proteinuria (median 3  g/d)
Nephrotic syndrome (43%), Hematuria (90%) 
Rare:
Digital ischemia 
Positive serum/urine EP/IFix: 100%
Abnormal sFLC level: 50%-75%
Plasma cell clone: 95%
Lymphocytic clone: 5%
Low C3 (35%-45%)
High serum C5bC9: 80% 
MGRS: 80%-90%
MM: 5%-15%
B-cell lymphoma: 6% 
Thrombotic microangiopathy with monoclonal gammopathy LM and EM: GBM duplication, mesangiolysis, subendothelial widening “fluff,” thrombosis
IF: no Ig deposits 
CKD (median s.creat 3  mg/dL)
Proteinuria (median 2-4  g/d)
Hematuria (90%) 
Common:
MAHA (50%-90%)
CNS, skin, peripheral neuropathy 
Positive serum/urine EP/IFix: 100%; Abnormal sFLC level: 28%
Plasma cell clone: 80%
Lymphocytic/LPC clone: 20%
Low C3 (33%)
High serum C5bC9: 77% 
MGRS: 90%
POEMS syndrome: 10%
MM: 5%
WM/B-cell lymphoma: 5% 
DiseaseRenal pathologyRenal manifestationsExtrarenal manifestationsHematologic findingsHematologic diagnosis
MGRS-related renal disorders with nonorganized Ig deposits      
Monoclonal immunoglobulin deposition disease LM: nodular glomerulosclerosis (2/3 of cases) with thickened TBM
IF: linear deposits along GBM, TBM, and vessels
LCDD: LC-only deposits (mostly κ)
HCDD: HC-only deposits with CH1 deletion (mostly γ)
LHCDD: deposits containing 1 LC and 1 HC lacking CH1 (mostly γ)
EM: punctate linear amorphous deposits along GBM, TBM, vessels 
CKD (median s.creat. 3  mg/dL)
Proteinuria (median 2  g/d)
Nephrotic syndrome (22%),
Hematuria (60%)
Hypertension (60%-80%) 
Common in LCDD (35%):
Cardiac disease
Liver disease
Peripheral neuropathy 
Positive serum/urine EP/IFix: 90%
Abnormal sFLC level: 99%-100%
Plasma cell clone: 95%-100%
Lymphocytic/LPC clone: <5%
Hypocomplementemia (low C4) if HCDDγ1 or HCDDγ3 
MGRS: 65%-80%
MM: 20%-35%
WM/B-cell lymphoma: 2% 
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits LM: MPGN, EPGN, MGN
IF: monotypic IgG (mostly IgG3κ, rarely IgM, IgA, LC only); granular deposits in mesangium and CW
EM: discontinuous nonorganized glomerular deposits 
CKD (mean s.creat. 2.8  mg/dL)
Heavy proteinuria (mean 6  g/d)
Nephrotic syndrome (50%)
Hematuria (80%)
Hypertension (38%) 
Absent Positive serum/urine EP/IFix: 20%-30%
Abnormal sFLC: 20%
Plasma cell clone: ~10%
Lymphocytic/LPC clone: ~10%
Hypocomplementemia 20%
Negative tests for cryoglobulins 
MGRS: 95%
MM: 3%-4%
WM/B-cell lymphoma: 1% 
MGRS-related renal disorders without Ig deposits      
C3GP with monoclonal gammopathy LM: MPGN, MesPGN, EPGN
IF: granular deposits of C3 only in mesangium and CW
EM:
C3GN: less electron dense subendothelial/subepithelial/ mesangial deposits
Dense deposit disease: highly electron dense sausage-like deposits within GBM 
CKD (median s.creat.1.8  mg/dL)
Proteinuria (median 3  g/d)
Nephrotic syndrome (43%), Hematuria (90%) 
Rare:
Digital ischemia 
Positive serum/urine EP/IFix: 100%
Abnormal sFLC level: 50%-75%
Plasma cell clone: 95%
Lymphocytic clone: 5%
Low C3 (35%-45%)
High serum C5bC9: 80% 
MGRS: 80%-90%
MM: 5%-15%
B-cell lymphoma: 6% 
Thrombotic microangiopathy with monoclonal gammopathy LM and EM: GBM duplication, mesangiolysis, subendothelial widening “fluff,” thrombosis
IF: no Ig deposits 
CKD (median s.creat 3  mg/dL)
Proteinuria (median 2-4  g/d)
Hematuria (90%) 
Common:
MAHA (50%-90%)
CNS, skin, peripheral neuropathy 
Positive serum/urine EP/IFix: 100%; Abnormal sFLC level: 28%
Plasma cell clone: 80%
Lymphocytic/LPC clone: 20%
Low C3 (33%)
High serum C5bC9: 77% 
MGRS: 90%
POEMS syndrome: 10%
MM: 5%
WM/B-cell lymphoma: 5% 

CH1, first constant domain; CNS, central nervous system; CW, glomerular capillary wall; EP, electrophoresis; EPGN, endocapillary proliferative glomerulonephritis; GBM, glomerular basement membrane; IF, immunofluorescence; IFix, immunofixation; LM, light microscopy; LPC, lymphoplasmacytic; MAHA, microangiopathic hemolytic anemia; MGN; membranous glomerulopathy; MesPGN, mesangial proliferative glomerulonephritis; MM, multiple myeloma; MPGN, membranoproliferative glomerulonephritis; POEMS, polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes; s.creat, serum creatinine; sFLC, serum free light chains; TBM, tubular basement membrane; WM, Waldenström macroglobulinemia.

or Create an Account

Close Modal
Close Modal